Search Within

Brian Carl Shaffer

  1. "DigITs Research Group"
Formats
  1. Meeting Abstract (39)
  2. Journal Article (17)
  3. Research Letter (1)
Groups
  1. Bone Marrow Transplant (57)
  2. Center for Hematologic Malignancies (57)
  3. Department of Medicine (57)
  4. DigITs Research Group (57)
  5. Hematologic Malignancies, Division of (57)
  6. Survivorship Research (54)

More Groups

People
  1. Molly Maloy (57)
  2. Miguel-Angel Perales (56)
  3. Sergio Giralt (55)
  4. Roni Tamari (50)
  5. Esperanza Papadopoulos (43)
  6. Ann Jakubowski (42)

More People

Years
  1. 2023 (1)
  2. 2022 (2)
  3. 2021 (5)
  4. 2020 (11)
  5. 2019 (14)
  6. 2018 (11)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (29)
  2. Bone Marrow Transplantation (9)
  3. Blood (8)
  4. Blood Advances (3)
  5. Transplantation and Cellular Therapy (3)
  6. Advances in Cell and Gene Therapy (1)

More Publications

Publishers
  1. Elsevier Inc. (32)
  2. American Society of Hematology (11)
  3. Nature Publishing Group (9)
  4. American Society of Clinical Oncology (1)
  5. John Wiley & Sons (1)
  6. Mary Ann Liebert, Inc (1)

More Publishers

Results (57)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Engrafting unit-recipient HLA-allele mismatch is not associated with an increased risk of transplant-related mortality (TRM) or inferior progression-free survival (PFS) after double unit cord blood (CB) transplantation (dCBT) in adults with hematologic malignancies
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Maloy, M. A.; Mazis, C.; Naputo, K.; Afuye, A.; Scaradavou, A.; O'Reilly, R. J.; Avecilla, S. T.; Castro-Malaspina, H.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Double-unit cord blood (CB) transplantation (dCBT) supplemented with haplo-identical CD34+ cells may be associated with enhanced neutrophil recovery but successful myeloid bridging is strongly influenced by haplo CD34+ cell dose and haplo-winning CB unit HLA-match
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Mazis, C.; Maloy, M. A.; Naputo, K.; Afuye, A.; Avecilla, S. T.; Castro-Malaspina, H.; Dahi, P. B.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Busulfan/melphalan/fludarabine (Bu/Mel/Flu) conditioning versus total body irradiation/thiotepa/cyclophosphamide (HFTBI/Thio/Cy) based conditioning in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) undergoing CD34-selected T-cell depleted allogeneic stem cell transplantation (alloSCT)
    Meeting Abstract

    Orozco, J. S.; Hilden, P.; Maloy, M. A.; Pappacena, J.; Buie, L. W.; Shaffer, B. C.; Papadopoulos, E. B.; Jakubowski, A. A.; Bhatt, V.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Letermovir prophylaxis demonstrates high efficacy in adult cytomegalovirus (CMV) seropositive cord blood transplant (CBT) recipients: A comparison with pre-letermovir era CBT controls
    Meeting Abstract

    Lau, C.; Politikos, I.; Maloy, M. A.; Naputo, K.; Afuye, A.; Devlin, S. M.; Bhatt, V.; Giralt, S. A.; Jakubowski, A. A.; Papadopoulos, E. B.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Letermovir in allogeneic hematopoietic cell transplantation: Beyond the label
    Meeting Abstract

    Lin, A.; Maloy, M. A.; Bhatt, V.; DeRespiris, L.; Griffin, M.; Lau, C.; Proli, A. J.; Barker, J. N.; Shaffer, B. C.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Impact of pre-transplant measurable residual disease on relapse incidence and progression-free survival in older AML/MDS patients following allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Lin, R. J.; Elko, T. A.; Devlin, S. M.; Perales, M. A.; Papadopoulos, E. B.; Castro-Malaspina, H.; Gyurkocza, B.; Shaffer, B. C.; Tamari, R.; Tallman, M.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experience
    Journal Article

    Lin, A.; Maloy, M.; Su, Y.; Bhatt, V.; DeRespiris, L.; Griffin, M.; Lau, C.; Proli, A.; Barker, J.; Shaffer, B.; more...
    Transplant Infectious Disease (2019)

    Fulltext@MSK | Save
  • Impact of geriatric vulnerability on outcomes of older patients in allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Lin, R. J.; Elko, T. A.; Devlin, S. M.; Flynn, J.; Jakubowski, A. A.; Shahrokni, A.; Dahi, P.; Perales, M. A.; Sanchez-Escamilla, M.; Tamari, R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • The SFGM-TC MDS score at day 180 is associated with post-transplant outcomes in patients with myelodysplastic syndrome who underwent CD34+ selected allogeneic stem cell transplant
    Meeting Abstract

    Alarcon, A.; Hilden, P. D.; Maloy, M.; Ruiz, J. D.; Sanchez-Escamilla, M.; YanĖƒez, L.; Castillo, N.; Tamari, R.; Shaffer, B.; Castro-Malaspina, H.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Letermovir in hematopoietic cell transplantation: Beyond the label
    Meeting Abstract

    Lin, A.; Maloy, M. A.; Bhatt, V.; DeRespiris, L.; Griffin, M.; Lau, C.; Proli, A. J.; Barker, J. N.; Shaffer, B. C.; Giralt, S. A.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save